Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Ennaid Therapeutics partners exclusively with Strides to manufacture life-saving oral Covid-19 Tablet14-06-2021
14-06-2021
Strides Pharma Science Ltd - 532531 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Strides Pharma Science Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here12-06-2021
Strides Pharma Science Ltd - 532531 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Strides Pharma Science Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here12-06-2021
Strides Pharma Science Ltd - 532531 - Voting Results Of Postal Ballot Pursuant To Regulation 44 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 And Scrutinizer'S Report.
With reference to the above, we would like to inform you that the aforesaid special resolution has been passed by the Members of the Company with requisite majority. The resolution is deemed as passed on June 11, 2021, which was the last date of e-voting for the Postal Ballot. Please find enclosed Voting Results along with Scrutinizer's Report.12-06-2021
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Sub: Newspaper Advertisment - Notice for transferring of equity shares to Investor Education and Protection Fund (IEPF) With reference to the captioned subject, please find enclosed a copy of the Notice published on June 10, 2021 in Business Standard (English Edition) and Navshakti (Marathi Edition) regarding the equity shares liable to be transferred to IEPF pursuant to Section 124 (6) of the Companies Act, 2013 read with relevant Rules. We request you to kindly take the above on record as required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.10-06-2021
Strides Pharma Science Ltd - 532531 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on May 31, 2021 for Pronomz Ventures LLP31-05-2021
Buy Strides Pharma; target of Rs 930: Motilal Oswal
Motilal Oswal is bullish on Strides Pharma recommended buy rating on the stock with a target price of Rs 930 in its research report dated May 28, 2021.31-05-2021
Strides Pharma says biotech associate Stelis in talks with global vaccine cos for manufacturing deal
The company declined to name the vaccine developer, but said it is accelerating the vaccine block infrastructure with ability to cater to multiple vaccine types including viral vector, protein subunit, RNA and DNA.27-05-2021
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of shares under Strides ESOP 2016 Plan27-05-2021